Hence, our results provide novel insight into the mechanism of apoptosis upon oncogene inactivation and suggest that induction of BIM-mediated apoptosis may be an important therapeutic approach for ALL. The gene discussed is BCL2L11; the disease is acute lymphoblastic leukemia.